港股異動 | 中海石油化學(3983.HK)漲8% 尿素期貨繼續走強
格隆匯7月13日丨中海石油化學(3983.HK)股價持續拉昇,現報2.97港元創2014年9月份以來新高,漲幅8%,最新總市值137億。尿素主力合約昨日大漲3.19%後,今日再度上漲0.34%,為連續第四個交易日上漲。光大期貨指,現貨市場經歷前期的震盪整理後,再次上調,國內主流地區尿素現貨價格上調幅度40至70元/噸不等,東北地區因農需結束價格下調20元/噸。整體來看,國內尿素市場情緒依舊高漲,預計期價在消息面的提振下繼續強勢向上運行。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.